Insulin resistance and type 2 diabetes: The IRIS study;Insulinresistenz und typ-2-diabetes: Die IRIS-studie

Diabetes und Stoffwechsel

Volumn 11, Issue 4, 2002, Pages 150-158

  Rihl, J ^a   Biermann, E ^a   Standl, E ^a  

^a Inst F Diabetesforschung Munchen   (Germany)

Author keywords

Epidemiology; Insulin resistance; Insulin Resistance Score; Macrovascular complications; Type 2 diabetes

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SCORING SYSTEM; STROKE; VASCULAR DISEASE;

EID: 0036322192     PISSN: 09420037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Cardiovascular Diabetes Disease
2. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: The Munich General Practitioner Project
3. A new look at the heart in diabetes mellitus: From ailing to failing
4. Microalbuminuria in a random cohort of recently diagnosed Type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich Area
5. Diabetes and atherosclerosis: An epidemiologic view
6. Diabetes other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
7. Epidemiology of macrovascular disease in diabetes
8. Mortality from coronary heart disease in subjects with Type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction
9. Insulin resistance: A multifaceted syndrome responsible for NIDDM. Obesitiy, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
10. Insulin resistance: Definition and consequences
11. Insulin resistance as a predictor of age-related diseases
12. Role of insulin resistance in human disease
13. Homeostasis model assessment. Insulin resistance in relation to 8-years of incidence of cardiovascular diseases
14. Homeostasis model assessment of insulin resistance predicts cardiovascular disease in type 2 diabetes mellitus
15. Insulin resistance predicts coronary artery calcification independent of CVD risk factors or diabetes status
16. Insulin sensitivity in subjects with type 2 diabetes
17. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (noninsulin-dependent) diabetes mellitus
18. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
19. Relationship between regional fat distribution and Insulin resistance
20. Cardiovascular risk continuum: Implications of insulin resistance and diabetes
21. Low insulin sensitivity is associated with clustering of cardiovascular risk factors
22. PAl-1 obesity, insulin resistance and risk of cardiovascular events
23. Plasma fibrinogen: A new factor of the metabolic syndrome: A population based study
24. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects
25. Clinical features of unrecognized myocardial infarction: Silent and symptomatic. Eighteen year follow-up: The Framingham Study
26. Increased cardiovascular disease (CVD) prior to the onset of type 2 diabetes (DM) in the San Antonio Heart Study: The role of insulin resistance (IR)
27. The glucose clamp technique: A method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin
28. Homeostasis model assessment: Insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man
29. Homeostasis model assessment as a clinical index of insulin resistance in Type 2 diabetic patients treated with sulfonylureas
30. Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity
31. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
32. International Diabetes Federation (European Region): A Desktop to Type 2 Diabetes Mellitus
33. Prevalence of Insulin Resistance in Metabolic Disorders. The Bruneck Study
34. Cardiovascular morbidity and mortality associated with the metabolic syndrome
35. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow-up of participants in the population study of women in Gothenburg, Sweden
36. The influence of body fat distribution on the incidence of diabetes mellitus
37. Syndrome X: 6 Years later
38. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the 11-year follow-up of the Paris Prospective Study
39. Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus
40. Lipoproteins and atherogenesis: Current concepts
41. Relation of High TG - Low HDL Cholesterol and LDL Cholesterol to the incidence of Ischemic Heart Disease
42. Low triglycerides - High High-density lipoprotein cholesterol and risk of ischemic heart disease
43. Low-density lipoprotein subclass patterns and risk of myocardial infarction
44. Small dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: Prospective results from the Québec Cardiovascular Study
45. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles
46. Hyperlipidemia in diabetes
47. Dyslipidemia is predictive of macrovascular events in type 2 diabetes while glycemia is not
48. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden
49. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients
50. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organization multinational study of vascular disease in diabetics
51. Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota
52. Epidemiology of persistent proteinuria in type 2 diabetes mellitus: Population-based study in Rochester, Minnesota
53. The role of circulating glucose and triglyceride concentrations and their interactions with other "risc factors" as determinants of arterial disease in nine diabetic population samples f rom the WHO Multinational Study
54. Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease - Chicken, egg, or neither?
55. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study